Clinical Trial Update: Single Ascending Dose Trial in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A single ascending dose Phase 1 trial in patients with Type 2 diabetes mellitus sponsored by Amgen was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Amgen | Conditions: Diabetes Mellitus | Phase 1 | Status: TERMINATED